Panel: Avandia to Remain on Market

Tags:
Cbsepisode, Avandia, Drugs, Diabetes, FDA, Panel, Medical Review, Heart, Side Effects, Deadly, Fatal, Medicine, Prescriptions, Doctors, United States, Rx, Glaxo, Smith, Klein, CBS Evening News

Add video views to your Facebook Timeline:

After years of debate over Avandia's safety, an advisory panel voted that the drug should remain an option for diabetes patients. As Jon LaPook reports, its fate now lies with the FDA.

  1. By: CBS
  2. Categories News & Events
  3. Views 5
  4. Added :20-Jul-10
Comments on Panel: Avandia to Remain on Market
Other comments on this video 0 Comments